In short
The episode covers three fast-moving news threads: (1) Trump’s UN General Assembly remarks on Ukraine and NATO, including his claim that Ukraine can “fight and win” to reclaim all territory and his suggestion that NATO nations should shoot down Russian aircraft that breach airspace; (2) a Secret Service cyber operation in the New York area involving 300 SIM card servers and 100,000 SIM cards, described as unprecedented and possibly aimed at disruption, threats, or criminal/foreign activity; and (3) controversy over pregnancy guidance on Tylenol (acetaminophen), with researchers and OBGYNs saying evidence does not support links to autism and criticizing “tough it out” messaging.
Guests
Michelle Jim Risco (Bloomberg White House and national security editor), Josh Wingrove (Bloomberg News senior White House correspondent), Jennifer Eubank (Andaman Strategic Advisor founder; former CIA deputy director for digital innovation), and Dr. Todd Ivey (Baylor College of Medicine; American College of Obstetricians fellow; former Houston OBGYN Society president).
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Chapters
Tap a time to open that second in VOTrump's Comments at the U.N.
0:00 to 0:56
Discussion on Trump's comments regarding Ukraine at the U.N. General Assembly.
“The thing about AI for business, it may not automatically fit the way your business works.”
Trump's Comments at the U.N.
1:54 to 2:28
Discussion on Trump's comments regarding Ukraine at the U.N. General Assembly.
“The Bloomberg Businessweek Daily Podcast with Carol Masser and Tim Stenebeck on Bloomberg Radio.”
The U.S. and Ukraine Relationship
2:28 to 3:40
Analysis of the fluctuating relationship between the U.S. and Ukraine.
“Let's see what Michelle Jim Risco has to say.”
Trump's Stance on NATO and Russia
3:40 to 4:50
Trump's controversial stance on NATO's response to Russian air incursions.
“I mean, I think we need to also look at this through the lens of what Trump is trying to achieve here.”
Economic Pressure on Russia
4:50 to 7:35
Discussion on economic strategies to pressure Russia and its allies.
“And of course, in successive administrations, the U.S.”
Trump's U.N. Speech Highlights
7:35 to 9:03
Recap of key themes from Trump's speech at the U.N. General Assembly.
“Catch us live weekday afternoons from two to five Eastern.”
Analysis of Trump’s Diplomatic Style
9:03 to 13:23
Commentary on Trump's unique approach to diplomacy and relationships with world leaders.
“Do want to mention a headline crossing President Trump to meet with the head of France, Mr.”
Changes to Immigration Policy
13:23 to 14:00
Insight into recent changes in immigration policy, especially regarding H-1B visas.
“So we don't know if this is sort of a friends-only thing, like, you know, melee and the other whatevers, or if it's a broader thing.”
Trump's H-1B Changes and Their Impact
14:00 to 15:06
Discussion on changes to the H-1B visa policy and its implications.
“How are you sussing out kind of what matters right now when it comes to the White House?”
Interview with Rafa Nadal
15:19 to 16:02
Nadal discusses his competitive spirit and experiences with injury.
“This week on Leaders with me, Francine Lacqua.”
Show all 20 chapters
Secret Service's Major Operation
16:02 to 16:30
Overview of the Secret Service dismantling a network threatening officials.
“You can also listen live on Amazon Alexa from our flagship New York station.”
Jennifer Eubank on Cyber Threats
16:30 to 20:46
Jennifer Eubank discusses the implications of the Secret Service's discovery.
“That's according to a statement on Tuesday.”
The Role of Telecommunications in Security
20:46 to 24:06
Eubank addresses the importance of telecommunications in national security.
“But bravo to all of the law enforcement and national security officials who worked together to thwart this, because who knows which path it could have taken?”
Trump's Tylenol Controversy
24:47 to 28:00
Discussion on the confusion caused by Trump's advice on Tylenol use.
“Catch us live weekday afternoons from 2 to 5 Eastern.”
Legal Concerns in Medical Recommendations
28:00 to 29:18
Discussion on the potential legal implications of government health recommendations.
“Well, that would be a concern for any of us.”
Studies on Acetaminophen and Autism
29:19 to 31:00
Overview of studies related to Tylenol usage during pregnancy and its alleged links to autism.
“Well, you know, there's been questions around this for a long time.”
The Tough It Out Statement
31:01 to 31:30
Critique of the statement suggesting pregnant women should tough out symptoms instead of taking medication.
“From a medical perspective, and those are his words, quote, tough it out.”
Understanding Autism and Its Causes
31:31 to 34:28
Exploration of the complexities surrounding autism and its multifactorial causes.
“Now, I think before any medicine is taken during pregnancy, whether it's an over-the-counter medicine or a prescription medicine, a conversation with your healthcare provider is in order.”
The Role of Healthcare Providers in Patient Decisions
34:29 to 37:08
Discussion on how patients should navigate conflicting medical advice and the importance of healthcare provider consultations.
“And it can offset some of the side effects of that.”
Vaccine Availability and Public Perception
37:09 to 40:05
Concerns over vaccine supply and public reluctance due to mixed messaging from authorities.
“you know, it's sheer decision-making is what we call it, where we talk to the patient about the risks of not taking a certain treatment, a certain vaccination, a certain medication.”
Transcript
Automatic transcript. May contain errors.0:00The thing about AI for business, it may not automatically fit the way your business works. At IBM, we've seen this firsthand, but by embedding AI across HR, IT and procurement processes, we've reduced costs by millions, slash repetitive tasks and freed thousands of hours for strategic work. Now we're helping companies get smarter by putting AI where it actually pays off, deep in the work that moves the business. Let's create smarter business. IBM.
0:30Carol Massar:Healthcare doesn't always work great. If you've ever waited on a refill or couldn't schedule an appointment, you get it. That's the kind of stuff Optum is changing. They're using data and technology to integrate patient care, pharmacy, and everything else. So healthcare is connected, not complicated. What's that look like? Cheaper prescriptions that are easier to get and care that looks at the whole person. How you need it. Optum is helping make healthcare work as one for everyone. Learn more at business.optum.com. Get the news you need in just 15 minutes. Start your day with Bloomberg Daybreak, the podcast with a global view on the stories that matter.
1:07I'm Nathan Hager.
1:08Carol Massar:And I'm Karen Moscow. Join us each morning for curated stories on current events, politics, business, and foreign relations. Plus one conversation on the day's biggest developments, all in just 15 minutes. Subscribe to Bloomberg Daybreak for a precise, thoughtful take on the stories that matter. Listen to Bloomberg Daybreak each morning on Apple, Spotify, or anywhere you listen.
1:54Carol Massar:The Bloomberg Businessweek Daily Podcast with Carol Masser and Tim Stenebeck on Bloomberg Radio. Geopolitics in the world at large, certainly a focal point for us. Makes sense with the U.N. General Assembly underway here in New York City. We did have some comments from President Donald Trump out on his social media platform saying, I think Ukraine, with the support of the European Union, is in a position to fight and win all of Ukraine back in its original form. This is coming after President Trump and Ukrainian President Volodymyr Zelensky met on the sidelines of the U.N. General Assembly earlier Tuesday, earlier today.
2:31Carol Massar:Let's see what Michelle Jim Risco has to say. She's Bloomberg White House and national security editor. She's out there in our D.C. News Bureau. Michelle, when it comes to the relationship with the U.S. and Ukraine, it goes back and forth here. What's the read on this? Yeah, well, it certainly goes back and forth. And as we all know, the president does like to be unpredictable. He likes to kind of maintain leverage and, you know, obfuscating what his thinking might be and what his actions might be. And so while this is pretty jolting and a 180 turnabout, really, in terms of his comments around who is best positioned to win this war, is kind of part and parcel of what we've seen from Trump and his sort of transactional diplomacy and his unpredictable diplomacy at that.
3:17Yeah, my jaw dropped when I saw this. Carol can attest to it because, you know, for months we've been hearing about the idea that, yes, this war could end. This is coming from the president. This war could end if Ukraine seeds some territory. And we took that to be to be land here. So this would seem like a direct 180. How does this happen with or let me rephrase the question, Michelle. Can this happen without U.S. support?
3:46Carol Massar:Well, that's certainly a high bar. I mean, I think we need to also look at this through the lens of what Trump is trying to achieve here. I mean, obviously, he's been expressing disappointment as recently as this morning in his UN General Assembly speech about Putin's behavior, the Russian president's behavior, as opposed to what Trump's expectations were coming into office as he admits he thought this would be one of the easier conflicts to resolve based on his relationship with Putin. That has not turned out to be the case. And it's frustrating the U.S. president to the point of him kind of turning his strategy on its head and now speaking as if Ukraine has the upper hand in the war.
4:27Carol Massar:So certainly some strategy in that respect. But to your point, yeah, it would be very tough, I think, to have this achieved without the support of the direct support of the U.S. But that is what Trump is willing to offer at this point. He's saying the U.S. is willing to continue to support NATO to give the European allies the resources that they need to pass on to Ukraine, but is loathe to get involved. And of course, in successive administrations, the U.S. has been loathe to get involved with boots on the ground to help out as well. Ah, but and the president did say he believed NATO nations should shoot down Russian aircraft that violated their airspace.
5:04Carol Massar:So the U.S. would continue to supply, as you said, the alliance with weapons. This was happening as he met with Ukrainian President Zelensky following recent incursions that have certainly alarmed allies when it comes to drones. He said, yes, I do. The president said when asked directly by a reporter if NATO allies should take down Russian aircraft during his meeting on the sidelines of the U.N. General Assembly. Again, the read on this, that seems pretty straightforward. Essentially, well, that's been an interesting developing story all day, just in the past few hours. I mean, essentially, Trump is giving his blessing for others to do what he is not willing to have the U.S.
5:45Carol Massar:get involved in. But at the same time, it still kind of contradicts or at least is at odds with the tone and tenor of what his secretary of state, Marco Rubio, said earlier in the day when he was asked about the Polish leaders, Tusk, his comments on being willing to shoot down a Russian aircraft. And Rubio kind of dismissed that and had a kind of vague line around, you know, diminishing that sort of prospect. But Trump now saying, yeah, go for it. Basically, if they're invading your airspace, NATO allies, you know, take them down. So he's certainly kind of, as we say, kind of ratcheting up his leverage against Putin in frustration over his mom and dad talking to each other.
6:30Carol Massar:Yeah, yeah, it certainly feels that way. What's the leverage that the U.S. actually has when it comes to Putin? What hasn't been tried? Well, certainly, I mean, there's a lot on the economic front. You know, in successive administrations, you always ask, you know, what more can be sanctioned? But, you know, as the Treasury Department always says and U.S. presidents have successively said, you know, there's always more that we can do. And certainly in Trump's portfolio, which has been very openly exposed in terms of what he wants to do on policy to ratchet up against Russia, he could move a little bit further to pressure other countries, including India and China and perhaps Hungary, as came up earlier today, to cease their Russian energy purchases.
7:15Carol Massar:He's already putting more pressure on European partners to do so and saying, you know, you can't be hypocritical about this. If you want me to apply these renewed penalties, you have to do it yourself as well. So he's offering Trump is offering different options for ratcheting up that pressure on Putin economically. You're listening to the Bloomberg Business Week daily podcast. Catch us live weekday afternoons from two to five Eastern. Listen on Apple CarPlay and Android Auto with the Bloomberg Business app or watch us live on YouTube. All right. We should keep in mind that we really saw a lot of unity at the most recent Fed meeting, some dissenters, the meeting beforehand.
7:56Carol Massar:Meantime, if you're at the U.N. this morning, there were no calls for unity. Instead, President Trump assailed the United Nations and other countries in a grievance-laden speech that accused the world body of offering nothing but empty words, labeled climate change a con job and warned open borders risk destroying nations. He also criticized the organization that housed his morning address. I ended seven wars, dealt with the leaders of each and every one of these countries and never even received a phone call from the United Nations offering to help in finalizing the deal. What is the purpose of the United Nations?
8:32The UN has such tremendous potential. I've always said it. It has such tremendous, tremendous potential. But it's not even coming close to living up to that potential. For the most part, at least for now, all they seem to do is write a really strongly worded letter and then never follow that letter up. It's empty words, and empty words don't solve war.
8:57Carol Massar:All right, that, of course, was President Trump, excuse me, addressing the U.N. General Assembly this morning. Do want to mention a headline crossing President Trump to meet with the head of France, Mr. Macron, and also the head of Uzbekistan while in New York City. So these headlines are going to continue to come. With more on the president's speech, you want to go right to it. Josh Wingrove is in the House, not in D.C. He's Bloomberg News senior White House correspondent. Josh, you cover the president, all his twists and turns. This was an interesting speech. It was. It's great to be here. Great to have you here.
9:28This is a rare treat for us here. Look, the Trump show hits the road every once in a while. And, you know, the aperture opens. And welcome, welcome to the second term. You know, he hit a lot of themes that he'd hit previously in this, although probably more strongly than in the past. basically he sort of assailed the un over as he mentioned climate and immigration is two big topics going so far as to basically completely dismiss the notion of climate change as a hoax uh but also in on immigration saying that it's the single biggest political issue of our era so trying to draw the draw a line in the sand but trump being trump he talked about the teleprompter uh not working this was sort of a bit of his in the campaign let's let's just say it's open to interpretation whether that was actually the case or not the un said the teleprompter was working fine of course was yeah but then was griping uh about about the escalator that was not working fine that was not i can confirm the escalator was not was not working and then later was working it seemed to get under his skin and that's when he went off about the uh renovation that he wished he'd done and told them you know you could be walking on marble you're walking on terrazzo flooring, you know that, right?
10:36So, you know, it's, it was a journey, a weave, as President Trump likes to say, but I think it just underscores not only his longstanding disdain for the UN, remember, the US is delinquent right now, and it's fun to support the UN, Trump has given no indication that he plans to change that. But also that kind of new grievances are adding on, in particular, he thinks he, you know, he's obviously kind of gently somewhat campaigning for a Nobel Prize, he talks about ending seven wars, and he's wondering where the UN has been, He sort of wanted credit for it, said they didn't get a phone call. But Trump being Trump, you know, he got off stage, sat down with Gutierrez and then was all smiles and nice.
11:11So pick your pick your lens, I suppose. You even mentioning other leaders who he had said things about, but then had run into personally, essentially saying, you know, I ran into this person. I can't believe I'm going to be talking about this. And it's kind of it for you who covers Trump, covers the president. It's not surprising because that's the way he is. But for world leaders who are sitting there who are not necessarily accustomed to following every comment that he makes, especially at the U.N., this was unconventional. I think that that's fair to say. I mean, if you're being sort of re-onboarded into a Trump speech after maybe six years, it had been since this last one, for sure, this is going to take you by storm.
11:50I do think that there are things to watch that will make news today for sure beyond the speech, including the bilateral with President Zelensky, which should be wrapping up just as we speak right around or just has wrapped up. Trump has really shifted on Zelensky a lot. He said today that it's remarkably brave what the Ukrainians are doing. That is a big shift in tone from January. And so that one we're watching, he sort of tacitly endorsed the notion of Native nations shooting down Russian planes. Does that have to do with the recent violations of airspace that we've seen? I think I personally would read that more as a Trump sort of hand wavy type of comment.
12:24I would not read that as like an emphatic shift in U.S. policy. He sort of he sort of danced around the drone issue. He danced around it again in a separate answer today. But he did say flatly, yes, he thinks that NATO should have the right to shoot down Russian planes, not drones, if they incur on NATO airspace. So we'll see. As you know, this is speaking of longtime grievances. It wasn't just the U.N. NATO, of course, he has had sort of a bumpy ride with. But he's been more pro-NATO as of late, in particular touting the increased defense spending pledges from Europe and Canada and other allies generally.
12:57So I think that one we got a lot of eyes on. This Macron meeting could be interesting. He made a little bit of news last night wandering the streets of New York, upset about the president's motorcade. What? We can all relate to that. Everybody knows a city bike is the way to go during the U.N. General Assembly. So if only he'd had a helmet, maybe would have seen the French leader on a city bike. We can hope. That would have been lovely.
13:20Carol Massar:Yes, yeah, we can hope. But that'll be good. Trump is hosting a reception tonight. We don't actually know who's going. So we don't know if this is sort of a friends-only thing, like, you know, melee and the other whatevers, or if it's a broader thing. So we'll see. We don't know right now whether they'll let the press in, but I'll be there waiting, hoping, praying. Josh, outside. Hey, I'll be here outside waiting for you guys to invite me in. On your city bike? Yeah. On your city bike? Yeah. I mean, against everything else that's going, We're still doing stories about the H-1B visas. I mean, there's just so much, Josh.
13:50Carol Massar:When you look at the president, I don't know how you guys do it because there's so much coming at you. Top of the White House agenda right now, because sometimes I feel like watch here, guys, but don't look at here, which is maybe something impactful. I don't know. How are you sussing out kind of what matters right now when it comes to the White House? I mean, Trump always likes to flood the zone. That's been a consistent theme throughout his presidencies. I think on the H-1B thing, this is a big change. And it's a little unclear to me whether they're shifting it on the fly. Remember, they had their big announcement Friday.
14:18Everyone's brains exploded. On Saturday, they started to, let's say, detail. Critics might say walk back some of the things. For instance, Secretary Lutnik said things on Friday that have not ultimately been the policy. And then today, the new development is sort of getting rid of the lottery system. We knew that was happening. Trump had signaled before the whole$100 ,000 fee thing that that was happening. But this is a huge change. And so, you know, whether its impact on the tech sector, on health care, all this is really up in the air right now. And it's, you know, part and parcel, obviously, with a complete overhaul of the American immigration system as he sees it.
14:52So, you know, people that have H-1Bs now are breathing a sigh of relief because there was a moment there where they were like, oh, shoot, we got to get back on U.S. soil, you know, in hours. But it doesn't look like that's the case. So for now, that's the shiny thing we're looking at.
15:04Carol Massar:So while you're here in town, come back. Yes. Josh Wingrove, he is Bloomberg News Senior White House Correspondent. Josh, thank you as always. Stay with us. More from Bloomberg Businessweek Daily coming up after this.
15:19Carol Massar:This week on Leaders with me, Francine Lacqua. I speak to tennis legend Rafa Nadal about how he stayed competitive despite injury. I was able to enjoy the victories probably more than if I will not have this issue. One iconic match. In my mind was, I am almost dead. And whether he misses playing. I don't miss tennis because there was nothing else to offer. Listen and watch Leaders with me, Francine Lacqua, on Bloomberg Television or wherever you get your podcasts. This is the Bloomberg Business Week Daily Podcast. Listen live each weekday starting at 2 p.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business app.
16:02You can also listen live on Amazon Alexa from our flagship New York station. Just say, Alexa, play Bloomberg 1130. Federal agents dismantled a network of devices in the New York area that was used to threaten senior U.S. government officials and bore signs of foreign involvement. This, according to the U.S. Secret Service, agents discovered more than 300 SIM card servers and 100 ,000 SIM cards in several locations within a 35 mile radius of New York City. That's according to a statement on Tuesday. day. The Secret Service moved quickly, given that any attack could have severely disrupted New York at a time when world leaders are gathering in the city for a meeting of the UN General Assembly.
16:42I want to bring in Jennifer Eubank. She's the founder of Andaman Strategic Advisor. She works with companies on cyber resilience, geopolitical risk, and more. She's also former deputy director of the CIA for Digital Innovation. She joins us from Virginia. Jennifer, good to have you back with us this afternoon, I want to talk about what the Secret Service discovered here. What does an attack like this mean or a potential attack like this mean? What would be the goal of something like this? What's your view? Wow. Thanks for the invitation today. And man, there's never a dull day in national security or cyber, is there?
17:17No. And today is obviously no exception. So what I'd say is this is quite literally unprecedented activity in its scale and I would say audacity, right? Just that you cited all the figures and in its eye-watering, what would have gone into planning such an activity? And so great question to start with is why, right? What is that for? And I think officials who've been working on this have very smartly been cautious about attribution so quickly because they're still investigating. But I think you can look at it as maybe three different bins. So first, there's disruption. This network, this technology could have taken out cellular communications, emergency communications, and enabled encrypted communications amongst various actors.
18:09So disruption would have been one possible explanation. Another is threats. I mean, it seems like a lot of technology for that, but there are some anecdotal reports of threats against U.S. officials being made from some of these devices and through these means. And then the third one, you know, could be some sort of criminal enterprise or clandestine network operating on a large scale. And certainly the timing around the U.N. General Assembly, the location of the equipment, all of that suggests something more. and I'll be very eager to see what officials start to say as they come up with more details.
18:48Carol Massar:You know, Jennifer, when something like this happens, how do we how do they know that it's signs of foreign involvement versus domestic involvement? Yeah, that's a really great question. And and there's there's a bit of speculation in there, because, as I mentioned, officials are being quite close lipped at this point because they're they're deep into investigating to get the details. But there have been anecdotal reports of some sign of connection between actors using this stuff and at least somebody in a foreign official position. I think it's really important not to go too far down that avenue of speculation, but investigators will be looking for these kinds of connections because, of course, the digital footprint is out there to be investigated.
19:36So they'll be combing through that using probably technical tools, using AI, using link analysis, using all sorts of things to see if they can put together a picture of who might be communicating with whom through this system that would help them understand who might be behind it.
19:50Carol Massar:Matt McCool, the special agent in charge of the Secret Service's New York field office, said the seizure was the largest operation of its kind the agency had undertaken. I mean, size and scope. I mean, I'm assuming that there's stuff going on all the time between nations and so on. But give us an idea, I mean, how big this operation seemed to be. Yeah, it's almost unimaginable, right? Just the volume, the scope, and you cited the metrics up front. So 300 SIM servers, 100 ,000 SIM cards, all kind of spread across a region. That is unprecedented. It really is. And I think the word I used at the beginning was it's audacious as well.
20:32It truly is. And so having come out of the world of intelligence for decades, I have never seen an activity like this. So I'm going to be tracking this one very closely, really want to understand a kind of how it was done, obviously why it was done, what the potential impact could have been. But bravo to all of the law enforcement and national security officials who worked together to thwart this, because who knows which path it could have taken? Was it going to be disruption, which would have been, you know, real pain and disrupt by nature of the word? Could it have facilitated threats? Could it have launched some other criminal activity?
21:10We don't know. Yeah, I think the question is to what end, like what would be the purpose of, you know, messing with a communication system such as that? One question that I have is about the communication of this terror plot or alleged terror plot that was thwarted and why the Secret Service communicated this, why they showed us pictures, and if that's rare to do in a situation such as this. It's interesting because I'm not sure we ever have had a situation like this. That we know of. Yeah. Well, yes. Okay. Because they did the great reveal. There we go. There we go. This was the first that was ever revealed.
21:47But I'm going to suggest that this is unique in its nature in terms of the scale and the scope. But is it unique to communicate a win such as this? Does a lot of stuff happen behind the scenes that we don't know about each and every day that keeps us safe? Absolutely. And I have to believe this was not as if, you know, discovered that moment and then they came out and had press release. There is a lot of work that went to getting to this point, I have to believe. And so one of the one of the good things that has been emphasized in government, certainly on the national security side and law enforcement side, has been transparency.
22:22And so maybe we're seeing a reflection of that. And it's always difficult because you don't have all the details. You know, people want more detail. But if you don't release information, then, you know, people are frustrated about that. Can I can I make one point about this, though, that I think is really important? Yeah, because if it's super interesting, we're going to be really focused on this for for some time. until it all is unraveled. But it really does showcase that telecommunications is a frontline national security issue right now. And so we've talked previously about intrusions like Salt Typhoon.
22:58That was the massive PRC-sponsored intrusions into our telecommunications networks across the country. We are just seeing telecommunications in various ways, just right in the crosshairs of very capable state cyber actors and criminal networks. Now, we don't know which one this is or if it's both. We don't have any idea just yet. But both are very, very focused on telecommunications. And that has economic impacts. It has security impacts on the ground. If we had talked about 9-11, 9-1-1, excuse me, 9-1-1 being disrupted or other communications has business impacts across every sector. So it's something that we really need to watch in this coming year.
Read the full transcript
23:42Carol Massar:15 seconds. Do we need global cooperation to stay on top of it or we just need to have a domestic focus on it real quickly? Absolutely. It is global. It is a global issue. We need to have partnerships all around the world. We need to emphasize public-private partnerships in the U.S. Right. Industry companies are going to see things that government does, but government's going to have strategic insights and resources that individual companies don't have. Jennifer Eubank, founder of Andaman Strategic Advisors, joining us from Virginia. Stay with us. More from Bloomberg Businessweek Daily coming up after this.
24:16Hi, I'm Barry Ritholtz, inviting you to join me for the Masters in Business podcast. Every week, we bring you conversations with the people who shape markets, investing and business. I speak with CEOs, Nobel laureates, market innovators and legendary investors. Whether you own stocks, bonds, real estate, commodities, even crypto, these are discussions you absolutely need to hear. Subscribe to the Masters in Business podcast on Apple, Spotify, or anywhere you listen.
24:46Carol Massar:You're listening to the Bloomberg Business Week Daily Podcast. Catch us live weekday afternoons from 2 to 5 Eastern. Listen on Apple CarPlay and Android Auto with the Bloomberg Business app or watch us live on YouTube. Watch in shares at Kenview, the parent company of Tylenol, really been bouncing around quite a bit in the last couple of days, up 2.3 percent, recouping some of Monday's drop. This is President Trump's call for pregnant women to avoid Tylenol. Drew Sharp criticism from researchers who say the advice ignores decades of evidence and could endanger mothers and babies. For more, we're joined by Jessica Nix, a Bloomberg News health reporter.
25:25Jessica, you and the team out with a story this afternoon about mounting confusion for patients. you all spoke to physicians about this. What did you find? How did they respond? Yeah, most physicians today are just generally confused about the guidance that's coming out. How are they going to interpret this? But a few of them are saying, you know, we're going to keep continuing on as normal. Keep talking to our patients about what works for them, what doesn't work for them. You know, one thing that's interesting here, and we're going to be speaking to Dr. Todd Ivey, a fellow in the American College of Obstetricians in just a minute.
25:56it. The organization is out with a statement that says it's irresponsible and still what they heard from President Trump and still recommends Tylenol during pregnancy. How atypical is it for a professional group such as the Academy of the American College of Obstetricians to recommend something that's counter to something that a government body such as the HHS would suggest? If you asked me that question a year ago, I would say very abnormal. This year, this is like the second or third time a American medical organization has gone against the advice of HHS. Notably, we've seen ACOG do different advice than than HHS on vaccines specifically for pregnant women and taking covid vaccines.
26:39Carol Massar:All right. Well, I want to put that question to Dr. Todd Ivey. He's fellow in the American College of Obstetricians, which is the professional membership organization of OBGYNs and associate professor at Baylor College of Medicine, former president of the Houston OBGYN Society. So, Dr. Ivey, weigh in on this. If it's recommended that maybe pregnant patients don't use Tylenol, I don't know, a recommendation from the government, how do you read it? Would you not recommend it to a patient? No, actually, I would absolutely recommend it. When we look back at the data, and this has been looked at, remember, we have over 20 years of research around this.
27:22There has never been proven causation for acetaminophen to any neurodevelopmental disorder during pregnancy. However, we know that the uses of acetaminophen in pregnancy for chronic pain, persistent headaches, and particularly fever reduction are incredibly important. And not dealing with those issues can lead to additional complications here in pregnancy.
27:47Carol Massar:One thing I want to ask you, Dr. Ivey, and I've seen this certainly in the OBGYN area, that your medical malpractice insurance is off the charts. And I'd had OBGYN who talked about a million dollars a year and gave up the OB part of it because it was so expensive. What I'm curious about, though, is if you have a government saying, maybe you shouldn't do this, does this potentially put you guys in a legal situation or legal quandary where you could be more of a target if something bad happens? Well, that would be a concern for any of us. However, I think it's important to remember. But you know what I'm saying?
28:25Carol Massar:If the government's coming out saying, maybe you shouldn't do this, and you guys say, nope, this makes sense. We've seen the research, the study, and then something goes astray. Is there kind of, you know, a new twist in all of this now and how you might approach something? Are you still going to say, nope, it makes sense. I'm going to do it. Well, you would have to prove causation. And I don't think that's able to be proven. And looking at the highest quality data, the best study designs, it's never been shown to be linked. And so I don't think that would stand. And certainly that would be a concern because we always want to do the right thing.
29:05That's really important to us. But I think it would be difficult to prove. Well, speaking, Dr. Ivey, of the causation doesn't always equal association in some of these studies. Talk to us about some of the studies that the Trump administration pointed to yesterday as the reason to come out with these new recommendations. Well, you know, there's been questions around this for a long time. And what we've seen, even the Society for Maternal Fetal Medicine and the FDA itself in 2017 and 2015 did reviews and did not find any causation. However, there was a consistent statement that was released in the journal Nature that suggested that maybe there could be some type of link.
29:52Well, 10 new studies have been released since that time that have clearly refuted this. The best study, I think, is the one released in the Journal of the American Medical Association in 2024, which looked at over 2.5 million children, 2.5 million. And they actually took into account some of the confounding variables that the poorly designed studies did not. And so they actually took siblings and matched them for a control group, meaning one sibling would get the Tylenol in utero and one sibling would not. And it proved there was no relationship that was proven. I just want to mention Kenview coming out over the weekend with a statement on this.
30:41They said, quote, this is the parent company of Tylenol. We believe independent sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned about the health risks and confusion this poses for expecting mothers and for parents. Dr. Ivey, the president said yesterday he suggested that pregnant women should only use Tylenol to control a fever if they can't tough it out. From a medical perspective, and those are his words, quote, tough it out. From a medical perspective and a medical communication perspective, I know that medical students study medical communication.
31:17How do you look at messaging such as that coming from the leader of the country? Well, I think that's a very unfortunate statement. I think pregnancy can be very difficult for some women. And I think telling them to, quote, toughen it out is really a poor approach. Now, I think before any medicine is taken during pregnancy, whether it's an over-the-counter medicine or a prescription medicine, a conversation with your healthcare provider is in order. And if they see fit, then I think you need to take the recommended dose for the shortest amount of time. And again, you know, no more than is recommended.
32:00Carol Massar:You know, you bring up autism, anybody brings up autism, and it's a very difficult situation. It's a spectrum. I know individuals who have kids who are now adults who are autistic, and it's a difficult thing. And I think we're still trying to figure out what is the cause, what are the causality, what are the connections, genetic or otherwise. I mean, how do you think about autism? And I'm sure you've seen it, unfortunately, in some of the folks who have had kids. I mean, how are we? It's still, there's a lot unknown, correct? And I understand everybody's looking to try and make sense of it. But I'm just curious, what's the smart medical thought around autism?
32:45I think you hit the nail on the head. There is a spectrum. There is a lot that is unknown. There's a lot more that we need to find out about it. You know, we know that it is a disorder of the way people receive, process, and communicate and interact with their environment. There will probably be, the cause will probably be multifactorial. And I think it's going to be an interplay of how things come together. But I think it's very unfortunate in families where a child has autism and to indicate that the mother or the parents did something wrong that caused this. The guilt with that would be tremendous.
33:30And in my opinion, it is completely, completely unnecessary. necessary. One thing that also came out of the administration yesterday is they're now recommending this new drug called lucovorin as a potential treatment for autism. Can you tell us a little bit about the science behind that, why they're pointing to this drug that's typically used for chemotherapy treatment and pain management? It is. It's lucovorin, and it actually is a form, a more naturally occurring form of folic acid. You know, folic acid has been important in pregnancy for years now. We know that it's related to neural tube defects, you know, or the lack of it is related to neural tube defects.
34:11So we've always recommended folic acid during pregnancy. And in reality, what makes a prenatal vitamin prenatal than just a regular vitamin is the amount of folic acid. Now, I think many more studies need to be done on this. The main use of lukevorn is exactly what you say in people who take chemotherapeutic drugs, whether it's for cancer or whether it's for arthritis. And it can offset some of the side effects of that. But I think it's as the drug of treatment, I think much more needs to be studied. Well, what do we know scientifically, and this is to Carol's and Jessica's question too, what do we know scientifically about the causes of autism?
34:59Well, we know that there, like I said, it's multifactorial. We know that there are many genetic causes. In some of my own patients, when we've done genetic analysis, we found different gene mutations and deletions that we know are associated with autism. There are likely some environmental factors that come into play as well. But our concern about some of these studies that they based some of these decisions on, they were poorly designed. They actually depended on a recall of patients about how much they took. And there's always a bias when you try to do recall. they had limited information on dosages and duration of exposure so you really cannot draw scientific conclusions from such poorly designed studies i just want two things leucovorin though
35:55Carol Massar:folic acid i remember taking it in a big way so it's not really something new it's not new it's not new at all um we have learned so much about neural tube defects which is a defect in the development of the neural tissue in the fetus. And we know that folic acid is incredibly important in the proper development of that. So I want to follow because we do know in the great reporting by our team of Brett Pooley, Jessica Nix, and Madison Muller, talking about these doctors at OBGYN practices in Atlanta fielding a lot of questions. I'm assuming you are fielding questions as well about all of this.
36:36Carol Massar:I am curious, do you feel or do doctors have a voice in Washington and are getting time with the HHS, Robert F. Kennedy, the secretary, or even with the White House? I think we've had somewhat of a difficult time doing that. You know, it seems to be recently that some of the scientific evidence is being ignored. I think that's very dangerous for patients. When patients come in and ask us about these things, you know, it's sheer decision-making is what we call it, where we talk to the patient about the risks of not taking a certain treatment, a certain vaccination, a certain medication. We talk about the risks and we talk about the benefits of each.
37:25And patients in consultation with their healthcare providers need to make those decisions. Well, speaking of some of this confusion that we're seeing coming out about Tylenol and autism, too, a lot of pregnant women are now also looking at what do we do about a COVID shot? So how can patients look at all of this confusing messaging coming out of the administration that's in conflict with what medical doctors are saying? And how can they navigate this world right now? Well, I think looking to your health care provider is the best place to go. I think we're relying on scientists, physicians, and healthcare providers to provide the best medical evidence and the highest quality medical evidence.
38:07You know, we always say that we practice evidence-based medicine and that we do that. And as science changes, we change our recommendations. But science hasn't changed on this. I just think someone's statement on this has changed. And so we still recommend the COVID vaccinations. I had one myself. We still recommend flu shots during pregnancy. We still recommend the Tdap. And we're now recommending RSV, the respiratory syncytial virus vaccination during pregnancy.
38:43Carol Massar:One last question. Do we have to be worried that there's not going to be enough vaccines because there's kind of interesting messaging and messaging that maybe not everybody needs the vaccine? Well, I hope not. That's always a concern. Supply is always a concern. We're finding patients coming in and requesting the COVID vaccinations, and we're having to send them out to pharmacies. And some pharmacies have them, and some are not. Some patients are having to look for them in order to receive them. You know, I've always been a believer. You know, I am 63 years old and I had the measles, I had the mumps, I had the chicken pox when I was a child.
39:22And I remember those. And I remember my sister looking at my face and saying, what are those bumps on your face? You know, and that's how we, you know, I was diagnosed. You know, I received the polio vaccine when I was a child. And so I feel like I've lived a great life with the benefit of vaccinations. And I think, unfortunately, our memories are often short. And sometimes the younger generation doesn't realize the benefits of what they've had. You know, I also remember the days of being an OBGYN provider when the pandemic first started and seeing, you know, on our local TV station, seeing the freezer trucks outside hospitals in El Paso, where they were placing the bodies of people that deceased from COVID.
40:11You know, hearing the stories of nurses that left Houston and went to New York to work, you know, in some of these COVID units, I had several patients that did that. And it's gut-wrenching. And I really hope people will stop, take a deep breath, and really listen to the high-quality, evidence-based research that's out there. and pay attention to what your healthcare providers are telling you. Well, Dr. Ivey, we really appreciate you taking the time and joining us this afternoon. That's Dr. Todd Ivey, fellow in the American College of Obstetricians and associate professor at Baylor College of Medicine, also former president of the Houston OBGYN Society.
40:53Also with us, Jessica Nix, our Bloomberg News healthcare team. Check out her story along with the rest of the healthcare team. You can do that on the Bloomberg Terminal and at Bloomberg.com.
41:04Carol Massar:This is the Bloomberg Business Week Daily podcast, available on Apple, Spotify, and anywhere else you get your podcasts. Listen live weekday afternoons from 2 to 5 p.m. Eastern on Bloomberg.com, the iHeartRadio app, TuneIn, and the Bloomberg Business app. You can also watch us live every weekday on YouTube and always on the Bloomberg Terminal.
42:01Carol Massar:We'll see you next time. you listen.
From the publisher
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
President Donald Trump said NATO nations should shoot down Russian aircraft that violated their airspace and struck a more sympathetic tone on Ukraine’s chances of winning the war.
He spoke as he met with Ukrainian President Volodymyr Zelenskiy following recent jet incursions that have alarmed allies.“Yes, I do,” Trump said when asked directly by a reporter if NATO allies should take down Russian aircraft during his meeting on the sidelines of the United Nations General Assembly in New York on Tuesday.
In a subsequent social media post, Trump said he believed that Ukraine, with the support of the European Union, was positioned not only to fight back but to reclaim all the territory taken by Russia since its invasion in 2022 — and perhaps more.
“Putin and Russia are in BIG Economic trouble, and this is the time for Ukraine to act. In any event, I wish both Countries well. We will continue to supply weapons to NATO for NATO to do what they want with them. Good luck to all!” Trump said.
Today's show features:
- Michelle Jamrisko, Bloomberg White House and National Security Editor
- Josh Wingrove, Bloomberg Senior White House reporter
- Jennifer Ewbank, Founder of Andaman Strategic Advisors
- Bloomberg News Health Reporter Jessica Nix & Dr. Todd Ivey, and Associate Professor at Baylor College of Medicine & a fellow in the American College of Obstetricians and Gynecologists
See omnystudio.com/listener for privacy information.
